Jazz Pharmaceuticals
JAZZ
£96.09
Share price
1.00%
Change (1 day)
2.06%
Change (1 year)
Categories
Revenue for Jazz Pharmaceuticals (JAZZ)
Revenue in 2024 (TTM): £3.17 Billion
According to Jazz Pharmaceuticals's latest financial reports the company's current revenue (TTM 
) is £3.14 Billion. an increase over the revenue in the year 2023 that were of £3.00 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Jazz Pharmaceuticals from 2005 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 | £3.24 B | 7.74% |
| 2023 | £3.00 B | -0.5% |
| 2022 | £3.02 B | 31.95% |
| 2021 | £2.29 B | 32.2% |
| 2020 | £1.73 B | 5.18% |
| 2019 | £1.64 B | 10.67% |
| 2018 | £1.48 B | 24.38% |
| 2017 | £1.19 B | -0.68% |
| 2016 | £1.20 B | 34.89% |
| 2015 | £0.89 B | 18.67% |
| 2014 | £0.75 B | 42.44% |
| 2013 | £0.52 B | 45.88% |
| 2012 | £0.36 B | 106.96% |
| 2011 | £0.17 B | 55.61% |
| 2010 | £0.11 B | 41.82% |
| 2009 | £79.37 M | 72.31% |
| 2008 | £46.06 M | 40.14% |
| 2007 | £32.87 M | 43.54% |
| 2006 | £22.9 M | 84.16% |
| 2005 | £12.43 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 | £1.55 B | -50.56% | 🇮🇪 Ireland |
 | £196.92 B | 6,152.85% | 🇺🇸 USA |
 | £40.03 B | 1,171.14% | 🇨🇭 Switzerland |
 | £12.80 B | 306.57% | 🇮🇱 Israel |